David Arnold, DO
General Practice · Downey
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
- Since medical school
- 8 years
- Edward Via Col of Osteo Medicine-Virginia Campus, 2018
On the public record
- Florida licence: Vol Relinquish
Offices
5 locations · Island Dermatology, Inc. · Howard Fein MD Inc · Steven E Hodgkin MD A Professional Corporation
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Arnold’s office to ask if they take your plan before you enroll.
State licence records
1 licence
- Florida OS16416Osteopathic Physician · since 2019 · expires 2024-03-31
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
1 placement
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Education
- Edward Via Virginia College of Osteopathic Medicine · DO2014–2018Medical school
Residency and fellowship
- RMH - Preliminary Medicine, INTERNAL MEDICINEColumbus, OH · 2018–2019
What else the board holds
Also licensed in
States the clinician told their board they are also licensed in. Only the states we check are verified.
Ohio
Original Medicare doctor bills
$33,544
Medicare paid this office $33,544 for 118 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 12 | $4,395 | $366 |
| Destruction of precancer skin growth, 15 or more growths | 20 | $2,992 | $142 |
| Biopsy of related skin growth, first growth | 39 | $2,944 | $74 |
| New patient visit (45+ min) | 22 | $2,859 | $130 |
| Short return visit (20+ min) | 33 | $2,751 | $79 |
See all 11 services
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 12 | $4,395 | $366 |
| Destruction of precancer skin growth, 15 or more growths | 20 | $2,992 | $142 |
| Biopsy of related skin growth, first growth | 39 | $2,944 | $74 |
| New patient visit (45+ min) | 22 | $2,859 | $130 |
| Short return visit (20+ min) | 33 | $2,751 | $79 |
| Return visit (30+ min) | 23 | $2,584 | $108 |
| New patient visit (30+ min) | 30 | $2,494 | $83 |
| Destruction of skin growth, 1-14 growths | 22 | $2,270 | $103 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 11 | $1,265 | $105 |
| Biopsy of related skin growth, each additional growth | 17 | $1,214 | $45 |
| Destruction of precancer skin growth, 1 growth | 12 | $423 | $35 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 61 | More than 88% of doctors who do this |
| Removal of skin cancer | 342 | More than 47% of doctors who do this |
| Removal of skin lesions | 485 | More than 86% of doctors who do this |
| Removal of tissue | 1-10 | None |
| Skin biopsy | 290 | More than 90% of doctors who do this |
Who their Medicare patients are
118 Original Medicare patients in 2024. Average age 72 · Under 65 14% · 85 and older 11% · Women 51% · Also on Medicaid 43% · Health risk score 1.66. Above the middle of the specialty; the typical general practice clinician is at 1.33.
Conditions among them: High blood pressure 71% · Diabetes 42% · Chronic kidney disease 23% · Coronary heart disease 22% · Depression 20% · Heart failure 16% · Cancer 14% · COPD 14% · Atrial fibrillation 10%.
The office billed $149,127, Medicare allowed $43,361 and paid $33,544; for 361 services of 32 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Medicaid work
$333 in 2024
Medicaid paid $333 for 33 billed services this clinician did in 2024, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 13 | $276 |
| New patient visit (30+ min) | 20 | $57 |
| 2024 | 33 | 2 | 20 | $333 |
Drugs they prescribed that Part D paid
$328,153
Pharmacies billed $328,153 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 860) in 2024. At or below the middle of the specialty; the typical general practice clinician is at 0%.
821 generic and 39 brand-name prescriptions · $328,153 in drug cost · 71 antibiotic prescriptions to 44 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cosentyx Unoready | 13 | $155,518 | $11,963 |
| Ketoconazole | 169 | $3,358 | $20 |
| Clindamycin Phosphate | 48 | $1,951 | $41 |
| Clobetasol Propionate | 64 | $1,923 | $30 |
| Triamcinolone Acetonide | 181 | $1,728 | $10 |
See all 16 drugs
| Cosentyx Unoready | 13 | $155,518 | $11,963 |
| Ketoconazole | 169 | $3,358 | $20 |
| Clindamycin Phosphate | 48 | $1,951 | $41 |
| Clobetasol Propionate | 64 | $1,923 | $30 |
| Triamcinolone Acetonide | 181 | $1,728 | $10 |
| Halobetasol Propionate | 19 | $1,412 | $74 |
| Fluorouracil | 19 | $1,363 | $72 |
| Fluocinonide | 20 | $511 | $26 |
| Metronidazole | 15 | $509 | $34 |
| Doxycycline Hyclate | 31 | $449 | $14 |
| Doxycycline Monohydrate | 20 | $320 | $16 |
| Hydrocortisone | 99 | $311 | $3 |
| Mupirocin | 39 | $275 | $7 |
| Terbinafine | 11 | $216 | $20 |
| Cephalexin | 15 | $183 | $12 |
| Valacyclovir | 13 | $97 | $7 |
Year by year
| 2024 | 860 | 331 | 0% (0) | 5% | $328,153 |
| 2023 | 88 | 56 | 0% (0) | None | $60,586 |
| 2019 | 71 | 15 | None | None | $2,363 |
| 2018 | 41 | None | 0% (0) | None | $827 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Ketoconazole | 13 | $270 | $21 |
| Triamcinolone Acetonide | 26 | $233 | $9 |
| Hydrocortisone | 13 | $59 | $5 |
2019: 1 drug
| Clopidogrel | 25 | $188 | $8 |
2018: 1 drug
| Clopidogrel | 13 | $130 | $10 |
Money from drug and device companies
$731 in 2025
| 2025 | 13 | 22 | None | $731 |
| 2024 | 10 | 34 | None | $899 |
| 2023 | 12 | 31 | None | $877 |
| 2022 | 11 | 17 | None | $697 |
| 2021 | 2 | 2 | None | $163 |
| 2020 | 1 | 1 | None | $104 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Tremfya | $191 | 6 payments
|
| Galderma Laboratories L.P. | None | $122 | 1 payment
|
| Genzyme | Dupixent | $83 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $50 | 2 payments
|
| STRATA Skin Sciences | Xtrac | $45 | 2 payments
|
| Ucb | Bimzelx | $43 | 1 payment
|
See all 22 published payments
| Novartis Pharmaceuticals | Meals · 2025-11-21 | Cosentyx | $34 |
| STRATA Skin Sciences | Meals · 2025-11-03 | Xtrac | $21 |
| LEO Pharma | Meals · 2025-10-27 | Adbry | $22 |
| Janssen Biotech | Meals · 2025-10-21 | Tremfya | $20 |
| Janssen Biotech | Education · 2025-10-16 | Tremfya | $100 |
| Janssen Biotech | Meals · 2025-09-19 | Tremfya | $20 |
| Novartis Pharmaceuticals | Meals · 2025-09-03 | Cosentyx | $17 |
| Abbvie | Meals · 2025-08-18 | Skyrizi | $29 |
| Organogenesis | Meals · 2025-08-15 | Puraply Wound Matrix | $38 |
| Galderma Laboratories L.P. | Meals · 2025-08-14 | None | $122 |
| Genzyme | Meals · 2025-08-12 | Dupixent | $50 |
| Botanix SB | Meals · 2025-08-11 | Sofdra | $16 |
| Janssen Biotech | Meals · 2025-08-08 | Tremfya | $11 |
| STRATA Skin Sciences | Meals · 2025-08-01 | Xtrac | $24 |
| Janssen Biotech | Meals · 2025-07-07 | Tremfya | $18 |
| Genzyme | Meals · 2025-06-30 | Dupixent | $34 |
| Fresenius Kabi USA | Meals · 2025-05-30 | None | $28 |
| Ucb | Meals · 2025-05-02 | Bimzelx | $43 |
| Janssen Biotech | Meals · 2025-04-23 | Tremfya | $22 |
| Lilly USA | Meals · 2025-04-16 | Taltz | $22 |
| Amgen | Meals · 2025-01-28 | Otezla | $25 |
| Amgen | Meals · 2025-01-09 | Otezla | $18 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $899
| Abbvie | Skyrizi | $320 | 11 payments
|
| Amgen | Otezla | $178 | 11 payments
|
| Genzyme | Dupixent | $153 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $81 | 3 payments
|
| Dermavant Sciences | Vtama | $41 | 2 payments
|
| Krystal Biotech | Vyjuvek | $32 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $26 | 1 payment
|
| Verrica Pharmaceuticals | Ycanth | $24 | 1 payment
|
| Blueprint Medicines | Ayvakit | $23 | 1 payment
|
| Lilly USA | Taltz | $20 | 1 payment
|
2023: $877
| Lilly USA | Taltz | $205 | 7 payments
|
| AbbVie | Botox | $176 | 4 payments
|
| Amgen | Otezla | $143 | 8 payments
|
| Genzyme | Dupixent | $80 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $79 | 2 payments
|
| Janssen Biotech | Tremfya | $39 | 2 payments
|
| Sun Pharmaceutical Industries | Winlevi | $28 | 1 payment
|
| Incyte | Opzelura | $28 | 1 payment
|
| Ucb | Bimzelx | $27 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $27 | 1 payment
|
| Kyowa Kirin | Poteligeo | $22 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $22 | 1 payment
|
2022: $697
| Abbvie | Skyrizi | $201 | 3 payments
|
| Galderma Laboratories L.P. | None | $191 | 1 payment
|
| Amgen | Otezla | $88 | 3 payments
|
| Lilly USA | Taltz | $54 | 3 payments
|
| Genzyme | Dupixent | $34 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $30 | 1 payment
|
| Sun Pharmaceutical Industries | Winlevi | $28 | 1 payment
|
| Janssen Biotech | Tremfya | $23 | 1 payment
|
| EPI Health | Cloderm | $20 | 1 payment
|
| Incyte | Opzelura | $16 | 1 payment
|
| Pfizer | Eucrisa | $12 | 1 payment
|
2021: $163
| Incyte | None | $135 | 1 payment
|
| Pfizer | Eucrisa | $28 | 1 payment
|
2020: $104
| Regeneron Healthcare Solutions | Libtayo | $104 | 1 payment
|
Professional record
- NPI
- 1003311051
- Licence
- FL OS16416Florida OS16416: Vol Relinquish
- Trained
- Edward Via Col of Osteo Medicine-Virginia Campus, 2018 · 8 years ago
- Group
- Island Dermatology, Inc. · Howard Fein MD Inc · Steven E Hodgkin MD A Professional Corporation
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X); Federal specialty code 207ND0101X (207ND0101X); Internal medicine (207R00000X); General practice (208D00000X)
- Mailing address
- 8345 Firestone Blvd Ste 310, Downey, CA, 90241
- NPI first listed
- 2018-03-29
- NPI last updated
- 2026-06-30
- NPI record certified
- 2026-06-30
This is when the NPI record was last certified, not a medical board exam.